Teva to pay up to $4.2 billion in U.S. to settle opioid claims

A Teva Pharmaceutical Industries building is seen in Jerusalem December 14, 2017. REUTERS/Ammar Awad

Nov 3 (Reuters) - Teva Pharmaceuticals (TEVA.TA) will pay up to $4.2 billion in the United States to settle claims related to its role in fueling the country's opioid crisis, New York Attorney General Letitia James said on Thursday.

The company will pay $523 million to New York state to settle claims in the state, James said.

Reporting by Leroy Leo in Bengaluru; Editing by Shailesh Kuber

Our Standards: The Thomson Reuters Trust Principles.